Clinical Trial Update: An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C

View source ↗

Summary

Observational study assessing dual and triple therapies based on Pegasys (peginterferon alfa-2a) in chronic hepatitis C; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2019-03-14